| Trial ID: | L4319 |
| Source ID: | NCT00960635
|
| Associated Drug: |
1,25-Dihydroxy-Vitamin D3 (Calcitriol)
|
| Title: |
Immunointervention With Calcitriol in New-Onset Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: 1,25-dihydroxy-vitamin D3 (calcitriol)|DRUG: placebo
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Institut fur Diabetesforschung, Munich, Germany
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: |Masking: |Primary Purpose: PREVENTION
|
| Start Date: |
2001-06
|
| Completion Date: |
2008-08
|
| Results First Posted: |
|
| Last Update Posted: |
2009-08-18
|
| Locations: |
Institut fuer Diabetesforschung, Munich, 80804, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00960635
|
